Egetis Therapeutics — Major Shareholding Notification 2023

Nov 2, 2023

Issuer Egetis Therapeutics AB (publ)

Holder

Handelsbanken Fonder AB

Instrument

Instrument	Aktie SE0003815604
Before the transaction
Shares	14,039,294
Voting rights	14,039,294
Transaction
Reason for major shareholding notification Corporate action
Date	31/10/2023
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	14,039,294
Directly held voting rights	14,039,294
Indirectly held voting rights	0
Percentage
Directly held shares	4.8 %
Directly held voting rights	4.8 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.8 %	14,039,294
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled - Cash settled
Total	4.8 %	14,039,294
Group total holdings
Voting rights 14,039,294 Percentage of voting rights 4.8
Published 02/11/2023 15:11
Contact
Name Ava Agah
Phone	0730576574 Email ava.agah@handelsbanken.se
CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25